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Background: The plant genus Fallopia is well-known in Chinese traditional medicine and includes many species
that contain bioactive compounds, namely phytoestrogens. Consumption of phytoestrogens may be linked to
decreased incidence of breast and prostate cancers therefore discovery of novel phytoestrogens and novel sources
of phytoestrogens is of interest. Although phytoestrogen content has been analyzed in the rhizomes of various
Fallopia sp., seeds of a Fallopia sp. have never been examined for phytoestrogen presence.
Methods: Analytical chemistry techniques were used with guidance from an in vitro estrogen receptor bioassay
(a stably transfected human ovarian carcinoma cell line) to isolate and identify estrogenic components from seeds
of Fallopia convolvulus. A transiently transfected human breast carcinoma cell line was used to characterize the
biological activity of the isolated compounds on estrogen receptors (ER) α and β.
Results: Two compounds, emodin and the novel flavan-3-ol, (−)-epiafzelechin-3-O-p-coumarate (rhodoeosein), were
identified to be responsible for estrogenic activity of F. convolvulus seed extract. Absolute stereochemistry of
rhodoeosein was determined by 1 and 2D NMR, optical rotation and circular dichroism. Emodin was identified by
HPLC/DAD, LC/MS/MS, and FT/ICR-MS. When characterizing the ER specificity in biological activity of rhodoeosein
and emodin, rhodoeosein was able to exhibit a four-fold greater relative estrogenic potency (REP) in breast cells
transiently-transfected with ERβ as compared to those transfected with ERα, and emodin exhibited a six-fold greater
REP in ERβ-transfected breast cells. Cell type-specific differences were observed with rhodoeosein but not emodin;
rhodoeosein produced superinduction of reporter gene activity in the human ovarian cell line (> 400% of
maximum estradiol [E2] induction) but not in the breast cell line.
Conclusion: This study is the first to characterize the novel flavan-3-ol compound, rhodoeosein, and its ability to
induce estrogenic activity in human cell lines. Rhodoeosein and emodin may have potential therapeutic
applications as natural products activating ERβ, and further characterization of rhodoeosein is necessary to evaluate
its selectivity as a cell type-specific ER agonist.
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The plant genus Fallopia (Polygonacae) is well known in
traditional medicines, and extracts have been used to
treat hepatitis, liver damage, inflammation, and post-
menopausal diseases [1-4]. Compounds isolated from rhi-
zomes of Fallopia sp. have demonstrated vasorelaxant,
anti-oxidant, anti-bacterial, anti-inflammatory, and anti-
tumor properties [4-7], which have likely led to the
Fallopia genus being widely used in traditional Chinese
medicines. Several polyphenolic compounds exhibiting es-
trogenic activity (phytoestrogens) have also been isolated
from the roots and rhizomes of numerous Fallopia (re-
cently Polygonum) species such as F. multiflorum, F.
cuspidatum, and F. japonica [8-12]. Many phytoestrogens
exhibit preferential activation of estrogen receptor beta
(ERβ) over estrogen receptor alpha (ERα) [13], and diets
high in phytoestrogen content have been correlated with
lower incidence of hormone-related cancers, namely
breast and prostate [14]. ERβ activation has an anti-
proliferative effect in breast cells and is viewed as a pro-
tective balance against ERα activation (associated with
proliferation) [15-17]. As such, there is interest in identify-
ing plant sources rich in phytoestrogen content as well as
discovering novel ERβ-selective phytoestrogens.
Recently, the rhizomes of Fallopia convolvulus (L.) Á.
Löve (black bindweed, Polygonum convolvulus L. [18])
were examined for their inhibitory effects on nitric oxide
production in lipopolysaccaharide-activated macro-
phages. Seventeen known and three novel phenolic com-
pounds were identified in the active extract [19].
However, extracts of F. convolvulus have not been exam-
ined for estrogenic activity nor has the polyphenolic
content of its seeds been studied. Additionally, despite
the wealth of information on the polyphenolic content
and/or bioactive properties in the genus Fallopia, no at-
tention has been paid to the content of the seeds. F. con-
volvulus is a widely distributed species, native throughout
Asia, Europe, and northern Africa and invasive in the
Americas and Australia [20]. Study of ancient herb con-
sumption in northern Europe indicates that the seeds of F.
convolvulus were consumed by humans in early pre-
Roman Iron Age and the Roman Iron Age (500 BC-400
AD) [21,22].
Several major classes of phytoestrogens exist including
isoflavones, lignans, stilbenes such as resveratrol, and
anthraquinones such as emodin and emodin-glycoside.
Flavanols, a class rich in biologically active compounds,
may undergo metabolism into ligands with estrogenic
activity [23]. For identifying phytoestrogens in the
Fallopia genus, mass spectrometry (MS), rather than
diode array detection (DAD) or ultra-violet (UV) absorp-
tion, has become the method of choice due to its high
specificity and ability to characterize unknowns through
fragmentation, with electrospray ionization (ESI) beingthe predominant ionization source. The bulk of estro-
genic compounds in Fallopia identified by MS are anthra-
quinones, stilbenes, and phenylpropanoids [6,9,10,24].
Fourier-transform ion cyclotron resonance (FTICR) MS
has been used to determine accurate mass (and elemental
composition), of estrogenic compounds [25]. 1H-NMR
and 13C- NMR, have been used to elucidate the structure
of many polyphenolic components from the genus
Fallopia [19,26,27]. However, if the polyphenols contain
chiral centers, NMR analysis will only yield the relative
stereochemistry of the compound, and it is then necessary
to use either X-ray crystallography or optical rotation
combined with circular dichroism to determine the abso-
lute stereochemistry [28]. To identify compounds with
certain biologic activity in a complex matrix, toxicant
identification evaluation (TIE) combines chromatography
separation and bioassay analysis to achieve rapid screen-
ing, isolation, and identification of compounds of interest.
TIE studies have been applied successfully to the genus
Fallopia to isolate and identify compounds with estro-
genic, antibacterial, anti-HIV, or anti-inflammatory proper-
ties ([10,29-31]). Use of the estrogen-sensitive carcinoma
cell line MCF-7 guided separation of the phytoestrogens
emodin and emodin 8-Ο-β-D-glucopyranoside from a
methanolic root extract of F. cuspidatum [8]. These two
compounds in addition to citreorosein were isolated from
F. cuspidatum using a recombinant yeast screening assay
(YES) [29]. Our objective was to determine whether the
seeds of F. convolvulus contain compounds which display
estrogenic activity (phytoestrogens), and, if so, the identity
of the responsible compounds and whether they displayed
ERβ-selectivity. In this study the estrogenic activity of
F. convolvulus seed extract was evaluated using the sta-
bly transfected recombinant human ovarian carcinoma
BG1Luc4E2 cell line which contains an estrogen-
responsive reporter gene [32]. Through TIE, active (es-
trogenic) components were isolated from F. convolvulus
seed and identified by instrumental analyses, and the
transiently-transfected human breast carcinoma SKBR3




Restriction enzymes were purchased from New England
Biolabs (Ipswich, MA), and antibodies were from Santa
Cruz Biotechnology, Inc (Santa Cruz, CA). Translation
grade L-[35S]-methionine (>400 Ci/mmol) was pur-
chased from MP Biomedical (Solon, OH). Standards 17-
β-estradiol (E2), emodin, and genistein were obtained
from Sigma Aldrich Chemical Company (St. Louis,
MO). Molecular grade dimethyl sulfoxide (DMSO) was
obtained from OmniPur. Molecular grade ethanol
(EtOH) and HPLC-grade solvents ethyl acetate (EtOAc)
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Louis, MO); HPLC-grade solvents acetonitrile (ACN),
water, glacial acetic acid (HOAc), and methanol (MeOH)
were obtained from Fisher Scientific (Waltham, MA).
Deuterated dimethyl sulfoxide (DMSO, 99.9%) was
obtained from Cambridge Isotope Laboratories (Andover,
MA), and silica gel (170–400 mesh) was obtained from
Fisher Scientific. Premium and charcoal-stripped fetal bo-
vine serum (FBS) were obtained from Atlanta Biologicals
(Lawrenceville, GA), Alpha Minimal Essential Medium
(α-MEM) was obtained Invitrogen (San Diego, CA),
Dulbecco’s Modified Eagle’s Medium (DMEM) was
obtained from Sigma (St. Louis, MO), Lipofectamine 2000
transfection reagent was from Invitrogen (San Diego, CA),
and Cell Culture Lysis Buffer and Passive Lysis Buffer
were from Promega (Madison, WI). Protein Assay Dye
Reagent Concentrate was from Bio-Rad (Hercules, CA).
Seeds (catalogue numbers 11716 and 11717 for F. convol-
vulus and F. dumetorum, respectively) were purchased
from Herbiseed Company (Twyford, United Kingdom),
and species authenticity was verified by Dr. Martin
Parham (Herbiseed). SKBR3 cells were purchased from
ATCC (Manassas, VA). All standards were stored at 4°C
+in borosilicate amber vials (Fisher Scientific) with PTFE-
lined caps.
General experimental procedures
HPLC for DAD and purification was performed using an
Agilent series 1100 HPLC instrument equipped with a
quaternary pump, autosampler, degasser, and Agilent
Chemstation software for LC 3D systems. A Phenomenex
Luna C18 column (150 mm × 4.6 mm I.D., 5 μm) with an
Alltech guard column (Econosphere C18, 5 μm) was used
at 23°C. LC/MS/MS analysis was performed using a triple
quadrupole mass spectrometer API 2000 (PE Sciex,
Concord, Ontario, Canada) operated in negative mode
electrospray ionization (ESI) and a Perkin-Elmer (PE)
series 200 equipped with a series 200 pump (PE), series 200
autosampler (PE), a CT0-10A column oven (Shimadzu),
and DGU-14A degasser (Shimadzu) with an injection vol-
ume of 10 μL in split-injection mode. Gradient elution with
a constant flow-rate of 1 mL/min was carried out with the
mobile phase program outlined in Additional file 1. Ion
source settings and potentials are shown in Supplementary
Information. The instrument was operated with Analyst
Software (v 1.3.1). FT-ICR MS analysis was performed
using direct infusion into an FT-ICR MS (ThermoFisher)
equipped with nano-ESI ion source, and spectra were
acquired and processed with MassWorks software.
Elemental composition of peaks was processed with
Molecular Weight Calculator for Windows 9x/NT/
2000/ME/XP (©Matthew Monroe). Emodin standard
(10 μg/mL) was used as an external standard for cali-
brating mass accuracy of peaks in samples. NMRspectra were recorded on Bruker 600 MHz and 800
MHz Avance III spectrometers equipped with 5mm
CPTXI cryogenic probes operating at 297 K. Sample
volume in deuterated DMSO was 550 μL. The chemical
shift (d) values are given in ppm and coupling constants
(J) in Hz. Further NMR parameters are in Additional
file 1. ECD spectrum was collected in MeOH using an
Olis DSM 20 CD spectrophotometer and optical rota-
tions were obtained on a Rudolph AUTOPOL IV polar-
imeter at wavelengths of 365, 405, 436, 546, 589, and
633 nm using a 1.0 dm cell. Specific rotations are
reported in degrees per decimeter at 23°C and the con-
centrations are given in grams per 100 mL of solvent.
Solvent used for optical rotations was MeOH (100%).
Construction and validation of ER plasmids
The human ERβ expression plasmid (ERβ/pcDNA3) was
constructed by PCR amplification of the human ERβ
segment (530 aa, GenBank: AF051427.1) out of pCMV5
(kindly provided by Dr. John Katzenellenbogen, Univer-
sity of Illinois) and insertion of this fragment at BstEII
and AflII restriction sites into the modified pcDNA3
construct, which was previously described [33]. This
construct contains a short 5′-untranslated sequence
from the β-globin promoter and a 3′-untranslated region
(~1.2 kb) from the mouse AhR gene that in previous
studies significantly increased the in vitro expression of
several proteins ([33] and data not shown). The human
ERα expression plasmid, pcDNA3.1 + ERα, was pur-
chased from Missouri S&T cDNA Resouce Center and
was confirmed by restriction digestion. The human ERα
fragment (444 aa, GenBank: AAD52984.1) from this
plasmid was PCR-amplified with primers containing
BstEII and AflII sites, and the plasmid ERα/pcDNA3 was
constructed by inserting this BstEII/AflII fragment into
the modified pcDNA3 vector. The generated plasmids
were verified by DNA sequencing. Plasmids ERβ/
pcDNA3 and ERα/pcDNA3were used as templates for
in vitro expression (Additional file 2); ERα and ERβ were
synthesized in vitro using the TNT Quick coupled tran-
scription/translation rabbit reticulocyte lysate system
(Promega). Briefly, 35S-Radiolabeled hERα and hERβ
were synthesized in separate reactions in vitro according
to manufacturer’s protocol, denatured, and subjected to
SDS-polyacrylamide gel electrophoresis, and the kDa of
each protein was determined by autoradiography of the
dried gel.
Cell culture and transient transfection assays
The recombinant BG1Luc4E2 cell-line containing a sta-
bly transfected estrogen-responsive luciferase reporter
gene was grown and prepared for bioassay analysis as
previously described [32]. Briefly, cells in 10 cm plates of
approximately 20% confluence were cultured in phenol-
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stripped FBS, for six days with daily media replacement.
Cells were then plated into white, clear-bottomed 96-
well tissue culture plates at a density of 750,000 cells/mL
and allowed to attach for 24 h. Cells were incubated with
carrier solvent EtOH (1% final solvent concentration),
the indicated concentration of E2, or respective chemical
or fraction treatment for 24 h at 37°C. Method blank
treatments were included if applicable. After incubation
cells were washed twice with PBS, followed by addition
of cell lysis buffer (Promega), the plates shaken for 20
min at room temperature to allow cell lysis, and lucifer-
ase activity in each well was measured using an Orion
microplate luminometer as previously described [34].
SKBR3 cells were grown and maintained in high-glucose
DMEM and 10% premium FBS. SKBR3 cells were cul-
tured in phenol red-free medium supplemented with
10% charcoal-stripped FBS for 48 h before transfection
and seeded in 24-well plates at a density of 300,000
cells/mL. 24 h after plating, cells were transfected for
24 h using Lipofectamine reagent (2 μL/well) according
to the manufacturer’s recommendations (0.2 μg of ER-
responsive reporter plasmid pGudLuc7ere [32] and 0.05
μg receptor plasmids (ERα/pcDNA3 or ERβ/pcDNA3)
or empty vector (pcDNA3.1+) per well, normalizing μg
DNA/well to 0.8 μg/well with empty vector). 24 h post-
transfection, SKBR3 cells were incubated for 24 h with
chemical, the cells harvested, and both protein concen-
tration and luciferase activity determined. Protein con-
centration was determined using the Bradford assay
[35]. Briefly, 5 μL/well SKBR3 lysate was incubated for
5 min at room temperature with 1X Bradford Reagent
(200 μL). Protein concentration was calibrated against a
standard curve of bovine serum albumin (0.05-0.5 mg/mL)
on the same plate and was measured as mg protein/mL
using a PhosphorImager (Molecular Dynamics).
Statistical analysis
Luciferase activity was expressed as relative light units
(RLU) for assays using BG1Luc4E2 cells or as a ratio of
luciferase RLU/mg protein for assays using SKBR3 cells.
Protein amount (mg) was calculated from concentra-
tions obtained in Bradford assay and the respective lucif-
erase RLU was divided by mg protein to obtain
luciferase RLU/mg protein. Average luciferase RLU (or
luciferase RLU/mg protein) values were calculated from
triplicate wells. Solvent luciferase RLU (or luciferase
RLU/mg) was subtracted from luciferase RLU induced
by chemical. In the case of extract and fractions, lucifer-
ase RLU induced by method blank was subtracted from
luciferase RLU induced by extract or fraction. Negative
values were reported as 0. Luciferase RLU and luciferase
RLU/mg protein from rhodoeosein, emodin, and genis-
tein, extracts, and fractions were calculated as a percentof maximum E2 activity (achieved with 1 nM E2 and 10
nM E2 in BG1Luc4E2 cells and SKBR3 cells, respect-
ively, and set as 100%) as previously described [36]. The
Student’s t-test (2-tailed, paired) was used to establish
significant difference of chemical/fraction/extract activity
from that of solvent or method blank (p ≤ 0.05), and
dose–response curves were fitted using a sigmoidal Hill’s
4-parameter algorithm (SigmaPlot v.9.0, Systat, San Jose,
CA), as described previously [37,38]. Half-maximal in-
ductions of each treatment (EC50) were determined as
described in [34].
Sample extraction and isolation of (−)-epiafzelechin-3-O-
p-coumarate
Extraction and isolation to determine the estrogenic
compounds in F. convolvulus is described in Additional
file 1. Seed was extracted using the following optimized
protocol. Triple aliquots of ground F. convolvulus seed
(25 g) were prepared. A method blank was included.
Samples were sonicated in EtOAc (25 mL) for 7 min
and liquid portions were collected. This process was re-
peated three times with an additional final solvent rinse
of the samples. Liquid portions for each sample were
centrifuged and re-centrifuged (550 g force) for 10 min
per centrifugation. Supernatants were collected and the
solvent evaporated from each sample at room temperature
using nitrogen evaporation. Residues were re-suspended
in EtOH and vacuum filtered using 0.2 μm Millipore
filters. Solvent was evaporated and residues were re-
suspended in H2O/ACN (1:1) 0.1% HOAc for preparative
HPLC (Program 2). An isocratic program was carried out
with A, water with 0.1% HOAc, and B, acetonitrile with
0.1% HOAc. The elution program was as follows: 20-30%
B in 2 min (1 mL/min), 30% B for 13 min (1 mL/min), 30-
100% B in 5 min (1 mL/min), with a flush of 100% B
for 2 min (2 mL/min), 100-20% B in 2 min (1 mL/min),
and 20% B for 1 min (1 mL/min (run-time 23 min).
Valve (direct to waste) timing was 1.8 min onwards.
Fractions were collected in 0.25 min intervals and evalu-
ated for activity in BG1Luc4E2 cells, and fractions 12–14
(containing compound 5) were combined and fractionated
resulting in fractions 12–13.5 that were combined and re-
fractionated to yield pure compound 5 (20.9 mg). Com-
pound 5 ((−)-epiafzelechin-3-O-p-coumarate) was then
evaluated for activity at different concentrations in
BG1Luc4E2 cells and maximal ERα and ERβ activity in
SKBR3 cells.
Results
Estrogenic activity of seed extracts and crude fractions
F. convolvulus and F. dumetorum seeds were extracted
and analyzed for estrogenic activity in human ovarian
carcinoma BG1Luc4E2 cells (Figure 1A). The seed ex-
tracts of F. convolvulus and F. dumetorum superinduced
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Figure 1 F. convolvulus seed induces activity in an estrogen-
responsive cell line. A. Seed extracts of F. convolvulus and F.
dumetorum agonize estrogen receptor in human ovarian carcinoma
BG1Luc4E2 cells. Seed (8 g) was extracted in EtOAc and BG1Luc4E2
cells were treated with indicated concentration of E2 or seed extract.
Luciferase activity in cell lysates was determined after 24 h. Values
represent the mean ± SD of triplicate determinations. Seed extract
concentrations at and above 8 g/mL caused significant cell death
and were not included in the analysis. B - Multiple fractions from
crude chromatography of F. convolvulus seed (8 g/mL) exhibited
greater estrogenic activity than whole seed extract in BG1Luc4E2
cells. Solvent composition of fractions 1–7 is described in Additional
file 1. Activity of treatments (fractions and negative control, Brassica
kaber) was expressed as a percent of E2 induction (1 nM). The
luciferase induction profile for F. dumetorum crude fractions was
similar to that shown here. Luciferase activity in cell lysates was
measured 24 h after treatment. Values with * indicate significant
difference above background using Student’s t-test (2-tailed, paired)
and represent the mean ± SD of triplicate determinations.
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respectively, of maximal luciferase levels caused by
17β- estradiol (E2). At seed amounts equal to and
greater than 8 mg on the bioassay, significant cell death
was noted which suggested presence of toxins in the
seed extracts (therefore values greater than 7 mg seed
are not included in the analysis). The similarity in theluciferase induction pattern between F. convolvulus and
F. dumetorum suggests the seeds of both species may
contain very similar estrogenic/antiestrogenic compo-
nents. The estrogenic properties of seeds from a
Fallopia species have not been examined, so compari-
son to seeds of other Fallopia species is not possible.
However, whole root extracts of a related species, F.
multiflorum, were capable of inducing ER-dependent
gene expression to ~75% of maximal E2 activity (from
0.1 mg root) in a yeast-based estrogen receptor assay
[39] and contains an estimated 0.4 mM E2 EQ/g herb
in the same receptor assay in a separate study [40].
After initial analysis on BG1Luc4E2 cells, F. convolvulus
seed extract was then crudely fractionated using normal
phase chromatography, and fractions (8 mg seed equiv-
alents/mL) were evaluated for estrogenic activity in the
BG1Luc4E2 cell line (Figure 1B). Significant luciferase
induction was observed in multiple fractions, which
suggested that more than one estrogenic agent may be
present in the seed extract. Luciferase activity of fraction 5
alone was superinduced to 118 ± 3% seed equivalent com-
pared to a toxic response for whole seed extract at the
same concentration (Figure 1B) suggesting the fraction-
ation removed some toxins from the whole seed extract
during the crude separation. The seed estrogen(s) was/
were suspected to contain both polar and nonpolar char-
acteristics as the eluting solvent of active fractions ranged
from 20% EtOAc in n-hex to 5% EtOH in EtOAC. Estro-
genic potency values of crude fractions were calculated
against an E2-dependent luciferase induction standard
curve (data not shown) using the methods of Natarajan
et al. [37]. Crude fractions 3, 4, and 6 of F. convolvulus
had respective estrogenic potency values of 0.21, 2.4, and
0.76 nM E2 equivalence (eq) per g seed with 4 ± 0.6%,
39 ± 1%, and 16 ± 1%, respectively of maximal E2 activ-
ity. Brassica kaber seed was used as a negative control
in the crude fractionation as the seed does not contain
phytoestrogens.
Isolation and identification of estrogens from F.
convolvulus seed
HPLC-DAD analysis of F. convolvulus seed extract
showed a minimum of nine phenolic compounds
(Additional files 3 and 4). The retention time and UV
spectrum of the nine compounds were confirmed in F.
dumetorum seed extract (Additional file 3). The estro-
genic activity of crude fraction 3 from F. convolvulus
seed extract was attributed to compound 1. For isola-
tion of the remaining estrogenic component(s), active
crude fractions 4–6 of F. convolvulus seed were com-
bined and subjected to HPLC fractionation (Figure 2).
Using Program 1 (H2O/ACN gradient), 44 fractions
were collected in 30 s intervals, fractions were evapo-
rated under a stream of nitrogen, and resuspended in
8 g F. convolvulus seed
Extracted in EtOAc, resuspended in n-hex
n-hex extract
Silica column, eluted with Solvents 1-7 (Additional file 7)
1 2 3 4 5 6 7
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HPLC fractionation (Program 2)
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NMR/OR/ECD
Compound 5: 2,3-cis-(2R,3R)-(–)-epiafzelechin-3-O-p-coumarate (2.2 mg)
Figure 2 Isolation strategy of estrogenic components from F. convolvulus seed. (+) indicates activity in BG1Luc4E2 cell line. Crude
















































Figure 3 Structure of 2,3-cis-(2R,3R)-(−)-epiafzelechin-3-O-p-
coumarate (rhodoeosein), depicted in absolute stereochemistry.
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Fractions were screened for activity using BG1Luc4E2
cells, and active fractions (21–23) were subsequently
combined and refractionated using HPLC Program 2.
These second-round fractions were screened for activ-
ity, and active fractions (9–16) were verified for purity
using Program 1 and combined. Compound 5, the
purified peak from these fractions, was then identified
as described below. While there was an insufficient
amount of compound 1 for NMR, it was identified as
emodin, an anthraquinone derivative, based on reten-
tion time, UV-spectrum, mass spectrum (including
MRM), and accurate mass (Additional files 1, 3, 4 and 5).
In addition to the fractionation scheme showed in Figure 2,
we developed an optimized isolation scheme for com-
pound 5 (Additional file 6) in which we were able to iso-
late 20.9 mg compound 5 from 75 g F. convolvulus seed
for subsequent functional analysis.
Chemical characterization of compound 5
The purified active (estrogenic) sample, compound 5
(2.2 mg), was identified by NMR, optical rotation, and
circular dichroism as 2,3-cis-(2R,3R)-(−)-epiafzelechin-3-
O-p-coumarate (rhodoeosein, [Figure 3]). Table 1 shows
the 1H and 13C shifts of rhodoeosein. Proton and carbon
spectra and COSY, NOESY, HMBC and HSQC correla-
tions were obtained to construct rhodoeosein in relative
stereochemistry (Additional file 7). COSY correlations
from NMR analysis were employed to identify vicinalrelationships among the aromatic protons in each para-
substituted phenolic ring. Coupling between H6 and H8
was also established. The trans Hα to Hβ relationship
was based upon the magnitude of the vicinal coupling
constant (15.8 Hz) which was obvious in the COSY
spectrum. H3 demonstrated vicinal cross peaks to H4α
and H4β. The trans relationship from H3 to H4β was
based upon the larger vicinal coupling constant (4.9 Hz)
as compared to H3 to H4α (2.4 Hz). Cross peaks in
NOESY from H3 to Hα and Hβ suggest a trans
Table 1 1H and 13C NMR spectroscopic data of compound
5 (600 MHz, δ in ppm)
Atom # 1H 13C
2 5.07 (s) 76.3
3 5.34 (m) 67.8
4α 2.65 (dd, J = 17.6, 2.4 Hz) 25.6
4β 2.92 (dd, J = 17.6, 4.9 Hz) 25.6
4a 97.2
5 156.6*
6 5.94 (d, J = 2.4 Hz) 95.6
7 156.5*
8 5.79 (d, J = 2.4 Hz) 94.3
8a 155.5
1' 128.6
2',6' 7.25 (d, J = 8.6 Hz) 127.8
3',5' 6.7 (d, J = 8.6 Hz) 114.8
4' 156.9
C = O 166.1
α 6.25 (d, J = 15.8 Hz) 113.6
β 7.38 (d, J = 15.8 Hz) 145.3
1" 124.6
2",6" 7.5 (d, J = 8.6 Hz) 130.5
3",5" 6.72 (d, J = 8.6 Hz) 115.8
4" 160.3
Compound was measured in DMSO. Chemical shifts are reported relative to
TMS (residual dimethylsulphoxide-D6 = 2.50 ppm for 1H and 39.51 ppm for 13C).
*Chemical shift assignment for C5 and C7 may be reversed. HMBC data did not
permit resolution sufficient to unambiguously assign the two resonances. This
finding has no impact on the proposed structure. A single broad –OH resonance
was observed at 9.9 ppm.
Wavelength (nm)















CAM-B3LYP (adjusted 20 nm)
Figure 4 Experimental and theoretical ECD spectrum of 2,3-cis-
(2R,3R)-(−)-epiafzelechin-3-O-p-coumarate (rhodoeosein; 100 μM
in MeOH). Experimental, B3LYP, CAM-B3LYP*. *CAM-B3LYP ECD
calculated prediction was adjusted +20 nm.
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containing Hα and Hβ. A small cross peak was observed
between H2 and H2’6′ thus supporting the point of at-
tachment of one para-substituted phenolic ring. From
the NOESY, H3 showed cross peaks to Hα and Hβ as
well as H2’6′. This supported the connectivity of C3-O-C
=O-α-β. Hβ revealed cross peaks to H6”2″. This sup-
ported the connectivity of Cβ to C1”. H8 was differenti-
ated from H6 by cross peaks to H2′ and H2. Thus H6 was
more distant from either phenolic ring. A weak cross peak
from H4α was observed to Hβ and Hα (not shown). From
HMBC, H3 showed a fundamental correlation to C =O
further supporting the connectivity of C3-O-C =O. Hβ
yielded cross peaks to C2”6″ indicating the attachment of
Cβ to C1”. Cross peaks from H2 to C2’6′ indicated the
connectivity of C2 to C1’. Other important correlations
were revealed with cross peaks from H4α and H4β to C4a
and C8a. H8 showed correlations to C7 and C8a. Also, H6
exhibited correlation to C4a, C7 and C5. The combination
of this information led to the unique assignments of car-
bons in the bicyclic ring (C2-C8a) and also supported theconnectivity of the remaining moieties. Resolution of the
HMBC experiment did not permit differentiation between
C5 and C7. The resonances were separated by only 0.1
ppm. The assignments of these two resonances could be
reversed without impacting any other assignments or the
proposed structure. Regarding the absolute stereochemis-
try, rhodoeosein contains two stereogenic centers (C2, C3,
Figure 3). As the majority of cis flavan-3-ols from natural
sources exist in the 2R,3R conformation [41,42], it was
not surprising that optical rotation combined with elec-
tronic circular dichroism (ECD) indicated the absolute
stereochemistry of rhodoeosein as 2R,3R (Figure 4).
Optical rotation values were negative at all tested wave-
lengths at two different concentrations of rhodoeosein in
MeOH (Additional file 7) which is in agreement with the
parent compound, (2R,3R)-(−)-epiafzelechin [43]. ECD
spectra were calculated for the 2R,3R conformation of
rhodoeosein using B3LYP and CAM-B3LYP predictions
and compared to the experimental spectrum (Figure 4).
The overlay of experimental ECD spectrum on predicted
spectra indicated good agreement for a 2R,3R confirm-
ation of rhodoeosein. The predicted ECD calculations (the
CAM-B3LYP prediction was adjusted +20 nm) for the
2R,3R confirmation of rhodoeosein showed a positive La
transition at ca.230 nm (corresponding to 3R), matching
that of the experimental ECD (Figure 4) and of the
Boltzmann-weighted parent compound [43-45]. The Lb
transition for the experimental spectrum of rhodoeosein
occurred at ca.300-310 nm whereas the Lb transition for
the predicted ECD spectra of the 2R,3R confirmation of
rhodoeosein occurred at ca.290 nm; however both pre-
dicted and experimental spectra showed a negative Lb
transition which corresponds to an R conformation at C2
[41] (it should be noted that both the experimental and
calculated Lb transitions for rhodoeosein were outside the
Log [Chemical], M


























Figure 5 Potency curves of phytoestrogens rhodoeosein and
emodin in human ovarian carcinoma BG1Luc4E2 cells. ● = E2;
○ = rhodoeosein; ▼ = emodin; Δ = genistein. Rhodoeosein was able
to superinduce luciferase activity in BG1Luc4E2 cells. Luciferase
activity was expressed as a percent of the maximum induction by E2
(1 nM) and was determined in cell lysates 24 h after treatment.
Incubation of cells with 0.25, 0.316, and 1 mM rhodoeosein caused
cell death and these values were not included in above analysis.
Values represent the mean ± SD of triplicate determinations.
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is 260–280 nm [46]). The parent compound, (2R,3R)-
(−)-epiafzelechin, also displays a negative Lb transition
[43-45]. From the mass spectrum of rhodoeosein, a parent
peak and a dimer of the parent peak were noted at 419 m/z
([M-1]) and 839 m/z ([2M-1]), respectively (Additional
file 7). Fragment peak 145 m/z was interpreted as the
3-O-p-coumarate portion of rhodoeosein (with the re-
mainder of the molecule as fragment 273 m/z).
2,3-cis-(2R,3R)-(−)-epiafzelechin-3-O-p-coumarate
(rhodoeosein)
Translucent pink oily film from 70/30 H2O/ACN; pink
in MeOH and EtOH; [α]23 D -151 (c 0.22, MeOH); For
1H and 13C NMR spectroscopic data, see Table 1; for CD
data (MeOH), see Figure 4; ESIMS m/z: 840.5 [2M], 419.4
[M-1], 273, 254.9, 229.1, 164.9, 145: 419.11360 [M-H]-
(C24H19O7, experimental 419.11322, calc 419.11307). For
peak abundances, UV spectrum, HMBC, HSQC, NOESY,
and COSY spectra, see Additional file 4: Table S1 and
Additional file 7.
Biological characterization of rhodoeosein and emodin
To characterize the estrogen activity of the novel phyto-
estrogen, rhodoeosein, we analyzed its activity over a
range of concentrations in two human cell lines: a re-
combinant human ovarian carcinoma (BG1Luc4E2) cell
line [32] and a human breast carcinoma (SKBR3) cell
line. In addition to E2, we also compared the activity of
rhodoeosein with that of emodin and of a well-known
phytoestrogen control, genistein. Both rhodoeosein and
emodin induced luciferase induction in the stably-
transfected BG1Luc4E2 cells. Rhodoeosein had a narrow
range of luciferase-inducing concentrations in BG1Luc4E2
cells (Figure 5); incubation with rhodoeosein below 31.6
μM resulted in no luciferase induction whereas incubation
with 119 μM and 158 μM rhodoeosein resulted in super-
induction of ER-dependent luciferase in BG1Luc4E2
cells (> 400% of maximum E2 activity). Incubation with
rhodoeosein at concentrations at or above 250 μM
killed BG1Luc4E2 cells (no toxicity was observed at
197 μM rhodoeosein). Based on maximum luciferase
induction at 158 μM rhodoeosein, EC50 of rhodoeosein
was 120 μM± 0.360 μM rhodoeosein, approximately 7
orders of magnitude weaker in potency than the E2
standard (Figure 5, Table 2). As a comparison, emodin
displayed half-maximal activity in BG1Luc4E2 cells at
1.3 μM emodin, approximately 5 orders of magnitude
weaker in potency than the E2 standard (EC50 18 pM ±
9.4 nM) and was able to induce luciferase to 104 ± 3%
of maximum E2 activity (Figure 5, Table 2). Emodin’s
estrogenic properties have been previously demon-
strated in a recombinant yeast screening assay (YES)
containing ERα; emodin was only two orders ofmagnitude weaker in estrogen response than the E2
standard [12]. When assessing genistein’s activity in
BG1Luc4E2 cells, we found genistein was able to super-
induce luciferase (190 ± 9% of maximum E2 activity)
and was, not surprisingly, more potent than either
rhodoeosein or emodin with half-maximal induction at
0.73 μM± 0.15 μM (approximately 4 orders of magni-
tude weaker than the E2 standard).
Although the BG1Luc4E2 cell line endogenously ex-
presses ERα, it does not appear to express ERβ protein
[32]. Given the critical role that ERβ plays in normal
physiological/endocrinological processes and tissue
health and in modulating the functional activity and
levels of ERα [47-50], interest in ligands that selectively
interact with ERβ has grown. To evaluate activity of
rhodoeosein and emodin on both ER subtypes,
rhodoeosin was incubated with SKBR3 cells transiently
co-transfected with an estrogen-response firefly lucifer-
ase reporter plasmid [32] and either an ERβ (ERβ/
pcDNA3) or ERα (ERα/pcDNA3) expression plasmid.
Firefly luciferase activity in each well was normalized to
protein amount and the resulting ratio expressed as a
percent of maximum induction by E2 (10 nM). In con-
trast to the results BG1Luc4E2 cells, rhodoeosein did
not superinduce ER-dependent gene expression in
SKBR3 cells transfected with either ER subtype; max-
imum luciferase induction by rhodoeosein was 78 ± 8%
and 80 ± 10% of E2 activity in SKBR3 cells transfected
with either ERα or ERβ, respectively (Figure 6). Concen-
trations of rhodoeosein greater than 100 μM rhodoeosein
Table 2 Potency comparisons of phytoestrogens
EC50 (M), REP
Cell-line E2 Rhodoeosein Emodin Genistein
BG1Luc4E2 1.8 × 10-11, 1 1.2 × 10-4, 3.5 × 10-7 1.3 × 10-6, 1.5 × 10-5 7.3 × 10-7, 2.5 × 10-5
SKBR3 (ERα) 2.0 × 10-11, 1 5.8 × 10-6, 4.0 × 10-6 1.3 × 10-6, 1.5 × 10-5 9.0 × 10-7, 2.2 × 10-5
SKBR3 (ERβ) 2.7 × 10-10, 1 1.8 × 10-5, 1.8 × 10-5 3.0 × 10-6, 8.9 × 10-5 8.3 × 10-8, 3.3 × 10-3
Comparison of concentration for half-maximal induction (EC50) and relative estrogenic potency (REP) for E2, rhodoeosein, and emodin in human carcinoma cell-
lines BG1Luc4E2 (ovarian) and SKBR3 (breast) transfected with either ERα or ERβ. Data for genistein is included for comparative purposes. REP = EC50
E2/EC50 chemical.
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http://www.biomedcentral.com/1472-6882/13/133resulted in significantly decreased protein concentration
in SKBR3 cells and are not included in the analysis. Half-
maximal induction (EC50) by rhodoeosein in ERα- and
ERβ-transfected SKBR3 cells was 5.8 μM± 1.5 μM and
18 μM± 0.4 μM, respectively (significantly less potent
than E2 which had EC50 values of 20 pM ± 1.5 nM and
270 pM ± 4.0 nM in ERα- and ERβ-transfected SKBR3
cells, respectively). The phytoestrogen control, genistein,
superinduced at 10 μM genistein in ERα-transfected cells,
but did not significantly superinduce in ERβ-transfectedLog [Genistein], M























































Figure 6 Phytoestrogens rhodoeosein and emodin isolated from F. co
carcinoma SKBR3 cells transiently transfected with ERα or ERβ. ● = ER
activity was normalized with protein concentration, was expressed as a per
cell lysates 24 h after treatment. Values represent the mean ± SD of triplica
rhodoeosein caused cell death and was not included in the above analysiscells. Genistein was the only phytoestrogen in this study
to exhibit a lower EC50 value in ERβ-transfected SKBR3
cells than in ERα-transfected SKBR3 cells (EC50 values
83 ± 120 nM and 0.90 ± 0.88 μM, respectively). Concen-
trations of genstein greater than 10 μM resulted in sig-
nificantly decreased RLU in SKBR3 cells and are not
included in the analysis. Emodin was also evaluated in
ER-transfected SKBR3 cells; maximum induction by
emodin was significantly greater than that of E2 in
ERα-transfected but not ERβ-transfected SKBR3 cellsLog [Emodin], M
























































nvolvulus seed induce luciferase expression in human breast
α-transfected SBKR3 cells; ○ = ERβ-transfected SKBR3 cells. Luciferase
cent of the maximum induction by E2 (10 nM), and was determined in
te determinations. Incubation of SKBR3 cells with 0.316 mM
.
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respectively (Figure 6). Concentrations of emodin
greater than 10 μM were toxic to SKBR3 cells and
therefore are not included in the analysis. EC50 values
for emodin in ERα-transfected and ERβ-transfected
SKBR3 cells were 1.3 μM± 0.24 μM and 3.0 μM± 1.0 μM,
respectively, (as compared to emodin’s EC50 value of
1.3 μM in BG1Luc4E2 cells). While emodin was a more
potent phytoestrogen than rhodoeosein for both ERα
and ERβ, it is present at much lower concentrations in
the seed (Additional file 4), and as such, rhodoeosein
likely is responsible for a greater amount of the estro-
genic activity of whole seed.
Discussion
Consumption of a diet rich in phytoestrogens has been
strongly correlated with beneficial effects on human
health [51,52]. Flavan-3-ols (the subclass of com-
pounds containing rhodoeosein) have been reported to
have a wide array of positive health effects such as
antioxidant, anti-viral, anticarcinogenic, antimicrobial,
and cardiopreventation (reviewed in [53]). Aside from
the current study, there is no report of phytoestrogenic
activity associated with flavan-3-ols. However, flavo-
noids, the broad class of plant compounds under which
flavan-3-ol is found, contains many phytoestrogens (genis-
tein, biochanin A, daidzein). Thorough structure-function
analyses of various flavonoids on estrogen-responsive cell
lines have correlated hydroxyls at the 7 and 4′ positions in
flavonoids to those at the 17 and 3 positions in E2 and
concluded that the flavonoid hydroxyls are essential for
estrogenic activity [54,55]. The estrogenic flavonoids in
these two studies contained between 2 to 4 hydroxyl
substituents. Accordingly, it is not surprising that
rhodoeosein is estrogenic since it contains hydroxyls at
the 7 and 4′ positions (Figure 3) and displays the clas-
sic A-ring structure which is shared by all known estro-
genic compounds [56]. A further phenomenon that
may allow for the estrogenic activity of rhodoeosein is
increased acidity of a hydroxyl through in-plane hydro-
gen bonding as suggested for other compounds by Fang
et al. [56]. Rhodoeosein possesses a benzylic hydrogen,
Hβ, that is in close proximity to an ester on C =Ο (in
conjugation with a hydroxyl in the 4″ position). This
ester may be able to form an intramolecular H-bond
with the in-plane C4 Hβ (Figure 3); the increased
electron-withdrawing capability of the C =Ο carbonyl
from an H-bond interaction with the C4 Hβ would in-
crease the acidity of the 4″ hydroxyl (favorable for ER
activity). In Zand et al. [55], a double bond between
carbons 2 and 3 was important for estrogenic activity of
a flavonoid as the double bond at this position in-
creased rigidity of the molecule and, therefore, ER-
affinity [56]; interestingly, rhodoeosein lacks a doublebond at this position in the molecule but contains, in
addition to the A- and B-rings, a large conjugated sys-
tem exhibiting rigidity (−O-p-coumarate) which may
lend favorable ER-binding attributes to the molecule. It
may be that the structurally-favorable aspects of
rhodoeosein (hydroxyls at the 7 and 4′ positions,
having 4 hydroxyl substituents, rigidity) outweigh the
absence of a double bond between C2 and C3. Add-
itionally, molecules exhibiting a certain measure of
hydrophobicity (where the molecule is hydrophobic
while containing a polar group on each end) bind to ER
with greater affinity [56]. Rhodoeosein contains not just
one set of opposing polar groups but two (7-OH and
4′-OH, 7-OH and 4″-OH) which sandwich large
hydrophobic regions (Figure 3).
Plants have a complex pathway for flavan-3-ol forma-
tion. Flavan-3-ols can be found in the seeds and fruits
but not leaves of certain plants, and a pathway for fla-
vonoid conversion in the plant from flavanone to flavan-
3-ol has been proposed [45]. The gene responsible for
the formation of flavan-3-ol through this cascade is
highly expressed in the seeds but not in the flowers or
leaf tissues [45]. Recently, F. convolvulus roots were ex-
amined for polyphenolic content [19]. Except for emo-
din, none of the 20 polyphenolic compounds (3 new, 17
known) found in the roots seem to exist in the seeds of
F. convolvulus (based on mass spectrometry supplemen-
tary data). This curious phenomenon of the polyphenolic
content of the seeds being unrepresentative of the con-
tent in the roots (aside from emodin) may be explained
through the multi-step flavonoid pathway illustrated in
Xie et al. [45]. It is thought that flavan-3-ols (known as
tannins in plants) play a mainly defensive role in the
plant against herbivorous animals, insects, fungi, and
other harmful agents [53]. However, as demonstrated
here and in other studies, flavan-3-ols exhibit complex
biological properties in human systems.
Although emodin’s behavior in ERα-transfected SKBR3
cells and BG1Luc4E2 cells was consistent (Table 2),
rhodoeosein showed marked cell-specific differences in
the potency and magnitude of luciferase induction be-
tween BG1Luc4E2 cells and ERα-transfected SKBR3
cells (Table 2). Luciferase activity was induced by
rhodoeosein in BG1Luc4E2 cells to a level greater than
that maximally induced by E2 and this superinduction
response suggests that rhodoeosein is also affecting
other signaling pathways that impact on ER-dependent
activation of luciferase expression from the reporter
plasmid. Numerous studies have not only demonstrated
that the functional activities of ER and other steroid hor-
mone receptors can be altered by posttranslational mod-
ifications (i.e. phosphorylation, acetylation and others),
but phosphorylation can also activate the transcriptional
activity of these receptors in the absence of ligand
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ERs or to GPR30 (a G-coupled protein receptor) can acti-
vate protein-kinase cascades which phosphorylate and ac-
tivate nuclear ERs as well as other signaling pathways and
transcription factors [57]. For example, tectoridin, a fla-
vonoid phytoestrogen, was found to exert its estrogenic
effects not through the ER but through an extracellular
signal-regulated kinase pathway [61]. Additionally, direct
or indirect stimulation of growth factor receptors can lead
to activation of protein-kinase cascades and hormone
receptor-dependent and independent gene expression re-
sponses. The enhancement of reporter gene expression
observed with rhodoeosein treatment in BG1Luc4E2 cells
but not SKBR3 cells could result from a rhodoeosein-
dependent stimulation of an additional signaling pathway
(s) that enhances the transcription of the luciferase re-
porter gene promoter. This pathway(s) may not present or
affected in the SKBR3 cells. Although superinduction has
been previously observed in the BG1Luc4E2 cell line [38],
the molecular mechanism responsible for superinduction
of ER-dependent gene expression in BG1Luc4E2 cells re-
mains to be elucidated.
Regarding half-maximal concentration differences be-
tween the two ER subtypes, we did not find that
rhodoeosein or emodin had lower EC50 values in ERβ-
transfected SKBR3 cells than in ERα-transfected SKBR3
cells which does not agree with previous literature on
phytoestrogens [13,62]. However, the ERβ-transfected
SKBR3 cells appear to be an order of magnitude less re-
sponsive to ER-ligands than the ERα-transfected SKBR3
cells as shown by the EC50 values of E2, rhodoeosein,
and emodin in both transfections (Table 2). Therefore,
we choose to assess potency by comparing the EC50
values of emodin and rhodoeosein directly to those of
the E2 standards in the ERα-transfected cells and the
ERβ-transfected cells (Table 2). This method of using
relative estrogenic potency (REP) has been previously
established in [63] where REP was defined as the ratio
between E2 EC50 and EC50 of the chemical. We have
also defined REP = EC50 of E2/EC50 of phytoestrogen,
and when compared to the half-maximal concentration
of the E2 standard, both emodin and rhodoeosein were
more potent in ERβ-transfected SKBR3 cells than in
ERα-transfected SKBR3 cells (Table 2). REP of
rhodoeosein in ERα-transfected SKBR3 cells was 3.4 ×
10-6 but in ERβ-transfected SKBR3 cells was 1.5 × 10-5,
a 4-fold increase in REP. The difference between emo-
din’s REP values in ERα-transfected SKBR3 cells and
ERβ-transfected SKBR3 cells was similar to that of
rhodoeosein; REP of emodin in ERβ-transfected SKBR3
cells was 8.9 × 10-5 whereas in ERα-transfected SKBR3
cells, the REP was 1.5 × 10-5, a 6-fold decrease. This is
in agreement with [62] where A YES assay transfected
separately with ERα or ERβ was used to examineemodin’s estrogenic activity; emodin had greater REP in
ERβ-transfected yeast cells than in ERα-transfected yeast
cells by approximately one order of magnitude. Our
findings are also in agreement with a study examining
binding affinity of several phytoestrogens to either ERα
or ERβ; compared to the E2 standard (set as 100%), rela-
tive binding affinity of genistein, biochanin A, coumestrol,
and diadzein were greater to ERβ than to ERα [64]. In our
assay, the control phytoestrogen genistein showed a 146-
fold increase in REP for ERβ compared to ERα (REP
values 3.3 × 10-2 and 2.2 × 10-5, respectively), in agree-
ment with [63]. ERα and ERβ have unique and overlap-
ping tissue distribution in the human body, and the roles
of the ER subtypes in the human body are now becoming
more clear (reviewed in [65] and [52]). Although ERβ acti-
vation may be associated with certain deleterious effects
(i.e. potential involvement in metabolic disorders leading
to diabetes [65]), beneficial roles of ERβ in the human
body include development and maintenance of the
brain, ovulation, prostate health, and anti-proliferative
roles in certain breast cancers. The effectiveness of
phytoestrogens, which exist in nature not as single
compounds but as complex mixtures in food matrices,
as therapeutic agents for existing diseases is still
unclear, but epidemiological studies indicate diets
containing a significant amount of phytoestrogens seem
to correlate with ERβ-mediated benefits (such as de-
creased incidence of breast and prostate cancers). The
higher REP values displayed by rhodoeosein and emo-
din in ERβ-transfected cells may indicate use of foods
containing these compounds as part of a comprehen-
sive plan for maintaining tissue health through ERβ-
mediated activity.
Conclusion
Seeds of F. convolvulus were identified as a novel source
of phytoestrogens from which we have isolated and chem-
ically characterized a novel phytoestrogen rhodoeosein.
Estrogenic activity of rhodoeosein was evaluated in two
human cell-lines in which we were able to demonstrate
cell-type specific effects of rhodoeosein. To our know-
ledge, rhodoeosein is the first published flavan-3-ol to
demonstrate estrogenic properties in vitro. In addition to
rhodoeosein, we also found that F. convolvulus seed con-
tains emodin (a known and potent estrogen), and these
compounds were also identified in the closely-related spe-
cies F. dumetorum. By comparing relative estrogenic po-
tencies (REP) of emodin and rhodoeosein in SKBR3 cells
transfected with either ERα or ERβ we found that both
phytoestrogens are more potent in ERβ-transfected cells
than in ERα-transfected cells and that emodin is more po-
tent than rhodoeosein on both ER subtypes. Similar differ-
ences in potency were observed in the BG1Luc4E2 cell
line. The estrogenic compounds in this study may regulate
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seeds [38]. Effects in vivo have not yet been assessed, but
the complex polyphenolic content of F. convolvulus seed
may indicate therapeutic potential.
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